Topic: PREVIOUS CONGRESSES

Fingolimod effective in all subgroups: analysis of phase III data

December 18, 2012  

New AAN guidelines for migraine prophylaxis

July 11, 2012  

Breastfeeding not a sustainable therapy

July 11, 2012  

Exploratory study of higher carbidopa dosing

July 11, 2012  

Emerging MS therapies: update on injectable drugs

November 30, 2011  

CONFIRM – Second phase III trial results for BG-12

November 30, 2011  

No benefits with omega-3 supplements

October 22, 2011  

Long-term safety of oral MS therapies: two reports

October 22, 2011  

Teriflunomide in MS: TEMSO extension data

October 22, 2011  

First choice, second thoughts: low persistence with MS therapies

October 21, 2011